This allows them to treat the body in a sustained manner, requiring less frequent dosage than other drugs
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
However, a similar number of participants across all groups reported increases in sweetness (Wegovy 19.4%, Ozempic 21.6%, Mounjaro 21.7%)
Immune and Antimicrobial Peptides Thymosin Alpha-1 has the most robust pharmacokinetic data in this group
However, In Colombia only some determinations have taken place in small groups (data without publishing), and there exist small work groups from certain universities like the Universidad del Rosario of Bogotas, who will soon give their results in relation to the prevalence of this alteration in the metabolism of hereditary type